SNX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TD Synnex looks like a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading above key support with a mild positive daily move, analyst sentiment is very strong and rising, and there is no evidence of insider, hedge fund, politician, or congress selling pressure. While the technical setup is only neutral-to-slightly constructive, the fundamental and analyst backdrop supports buying now rather than waiting. Given the user's impatience and preference to not wait for a perfect entry, this is a buy.
SNX is in a mildly constructive but not overextended trend. Current price is 233.98, above pivot support at 231.98 and well above S1 at 223.99. Resistance sits at 239.98 and then 244.92. RSI_6 at 52.51 is neutral, indicating balanced momentum. MACD histogram is -2.391 and still below zero, so near-term momentum is not fully bullish yet, but the negative contraction suggests downside pressure is easing. Moving averages are converging, which usually signals a developing trend rather than a breakdown. Overall, the chart is neutral to slightly bullish with room to test resistance.
["Multiple analysts raised price targets sharply in late April and early May, with targets ranging from $250 to $271.", "UBS cited strong hyperscaler demand and mid-teens EPS CAGR through FY28.", "BofA highlighted Hyve as an underappreciated asset with strong growth and higher margins.", "RBC and Morgan Stanley both pointed to strong Q1 results and above-consensus guidance.", "No negative news was reported in the last week.", "Options data leans bullish, with low put-call ratios."]
["MACD remains below zero, so near-term momentum is not fully confirmed.", "RSI is neutral rather than strongly bullish.", "Hedge funds and insiders are both neutral, so there is no strong ownership accumulation signal.", "No recent news flow means fewer short-term catalysts from headlines.", "Financial snapshot data is unavailable, so the latest quarter growth metrics cannot be directly confirmed here."]
Latest quarter financial data is not available in the provided snapshot, so I cannot quantify revenue or EPS growth directly. However, analyst commentary repeatedly references a strong fiscal Q1 beat and Q2 guidance above Street expectations, which suggests recent quarterly performance was solid. The broader narrative from analysts is that TD Synnex is sustaining profitable growth, benefiting from strong distribution execution and hyperscaler-related demand.
Analyst sentiment is clearly positive and has improved recently. UBS, BofA, RBC, Morgan Stanley, Goldman Sachs, and Barrington all raised price targets in late April and early May, mostly while keeping Buy, Outperform, or Overweight ratings. Target prices moved up into the $250-$271 range, with Morgan Stanley citing a street-high target. JPMorgan remains more cautious at Neutral with a $220 target, but even that is below the current cluster of higher targets. Wall Street pros are generally constructive: the bullish case centers on Hyve, hyperscaler demand, strong Q1 execution, and margin upside. The main con is that some near-term strength may have been helped by pull-forward demand, and one major firm still stays Neutral.
